CEO Update | 17 May 2021

As the COVID-19 pandemic continues worldwide, I chaired an emergency Board meeting of the International Council of Biotech Associations (ICBA) on what more our sector can do to help the global vaccination effort.

How are companies across the Bruntwood SciTech network improving access to better healthcare, medicines and treatments?

The Bruntwood SciTech network is home to some of the UK’s most pioneering science companies, from small medtech startups and scaleups, all the way through to global life science companies that are uncovering world-leading discoveries, creating new medicines and shaping the future of our healthcare. So who are some of the UK’s most innovative life science businesses at the forefront of helping to create a fairer and healthier world?

The Babraham Research Campus sets out its vision and ambition for its future

Cambridge, 12th May 2021: The Babraham Research Campus’ vision is to be one of the best places in the world for discovery bioscience research and innovation; a leading sustainable ecosystem to start, nurture, scale and grow bioscience business.

BIA reaction to the Queen's Speech

The Government has used the Queen’s Speech to highlight its ambition to lead the world in life sciences as part of its plans for economic recovery from the COVID-19 pandemic on the back of the successful vaccination programme. Improving health, creating jobs and levelling up were other key themes set out as the foundations for the Government’s policy agenda.  

CEO Update | 10 May 2021

Jabbed! a TV documentary telling the inside story of the UK Vaccines Taskforce is on Channel 4 this evening at 10pm. Tune in to see interviews with familiar faces including Kate Bingham and Ian McCubbin. I hope the documentary puts front and centre the early work done by the BIA COVID-19 Vaccine Manufacturing Taskforce as part of the UK’s great vaccine story.

Magdalen College seeks Strategic Partner to accelerate development of The Oxford Science Park

Oxford, UK, May 10 2021 – Magdalen College Oxford, owner of The Oxford Science Park (TOSP), one of the UK’s leading parks for science and technology companies, has announced that it is seeking a strategic partner with which to accelerate development of the Park.

Abingworth raises $582 million for new Clinical Co-Development Fund – ACCD 2

New oversubscribed global fund to invest in late-stage clinical programmes with pharma/biotech partners Abingworth has closed on over $1 billion in 2021 in two new funds

Applications invited for Accelerate@Babraham life science start-up competition

Five months, five companies: Life-changing ideas, game-changing support. Accelerate@Babraham, the bio-entrepreneurial incubator initiative founded and developed by the Babraham Research Campus - supported by key industry and investor organisations - opens applications for its 2021/22 cohort today.

QUAY PHARMA WINS QUEEN’S AWARD FOR INDUSTRY

Leading pharmaceutical contract development and manufacturing organisation (CDMO) Quay Pharmaceutical has been honoured with a Queen’s Award for Enterprise, the UK’s highest accolade for business success. The company won its award for International Trade.

Discovery Park & National Horizons Centre agree partnership

A partnership between the National Horizons Centre and Discovery Park, the Life Sciences Opportunity Zone for ambitious companies, is promising to bring opportunities to both organisations.